Fritextsökning
Innehållstyper
-
Storägare vill förhandla
Fondbolaget Blackrock och kapitalförvaltaren Grantham Mayo uppmanar Astrazenecas styrelse att hålla nya samtal med Pfizer.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Grönländsk genvariant påverkar diabetes
Andelenfall av typ 2-diabetes på Grönland har ökat dramatiskt de 25 senaste åren. En del av förklaringen ligger i generna. Det visar Niels Grarups forskning och...
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Godkände 48 nya läkemedel 2019
Färre än 2018 men mer än dubbelt så många som år 2016.
-
Hello Johan Billiet...
...Flanders Investment and Trade Agency, why are there so many Belgian companies represented at Biotech Forum?
-
Hey there Summer Eriksson......
.....biomedical analysist at Akademsika sjukhuset in Uppsala. Why are you here at Biotech Forum and Scanlab?
-
Vaccinkandidat används i pågående utbrott
Ebolavaccin under utveckling skickas till Demokratiska republiken Kongo.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Han tar plats i Lipums styrelse
Ledde utvecklingen av Lipums huvudkandidat på Scilifelab.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Pfizer överväger nya bud
Obama-administrationens nya skatteregler hämmar inte bolagets köplust.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Multilabel plate readers with luminescence capability
The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...
-
Varnar för Astra-preparat
FDA går ut med ännu en varning för läkemedelsklassen SGLT2-hämmare.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
BREAKING